Pathstone Holdings, LLC Ginkgo Bioworks Holdings, Inc. Transaction History
Pathstone Holdings, LLC
- $21.9 Billion
- Q2 2024
A detailed history of Pathstone Holdings, LLC transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 62,494 shares of DNA stock, worth $383,713. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,494
Previous 53,202
17.47%
Holding current value
$383,713
Previous $61,000
67.21%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$879 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$853 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$825 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$429 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$258 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $7.91B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...